Belgium· BE-AMP-SAM015495-00
Deanxit 10 mg - 0.5 mg
A melitracen und psycholeptika product containing flupentixol dihydrochloride, registered in Belgium by Lundbeck. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Melitracen und psycholeptika is registered in 3 of 19 countries.
Countries holding a registration under ATC N06CA02 (melitracen und psycholeptika), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Melitracen und psycholeptika · ATC N06CA02
3 / 19 countries
- Belgiumprice
- Norwayprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Flupentixol Dihydrochloride
- Manufacturer
- Lundbeck
- Country
- Belgium (BE)
- ATC code
- N06CA02
- ATC class
- Melitracen und Psycholeptika
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb3179959
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for melitracen und psycholeptika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Melitracen und psycholeptika · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Melitracen und psycholeptika in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDepixol 3mg tabletsLundbeck Ltd
- SwedenFluanxol 0,5 mg Filmdragerad tablettH. Lundbeck A/S
- FinlandFluanxolH. Lundbeck A/S
- NorwayFluanxol2care4 ApS
- IcelandFluanxol MiteH. Lundbeck A/S*
- CzechiaFLUANXOLH. Lundbeck A/S, Valby
- GermanyFluanxolH. Lundbeck A/S
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Fluanxol
- Bulgaria · Флуанксол
- Czechia · Fluanxol
- Germany · Fluanxol
- Denmark · Fluanxol, Fluanxol Mite
- Estonia · Fluanxol
- Finland · Fluanxol
- France · Fluanxol
- United Kingdom (Northern Ireland) · Depixol, Fluanxol
- Iceland · Fluanxol Mite
- Lithuania · Fluanxol
- Luxembourg · Fluanxol
- Latvia · Fluanxol
- Malta · Fluanxol
- Netherlands · Fluanxol
- Norway · Fluanxol
- Poland · Fluanxol
- Sweden · Fluanxol
- Slovenia · Fluanxol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4d1c0037-fc6e-4171-8938-fdad82b7b102 GET /v1/drugs/4d1c0037-fc6e-4171-8938-fdad82b7b102?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Deanxit 10 mg - 0.5 mg",
"name_fr": "Deanxit 10 mg - 0.5 mg",
"name_nl": "Deanxit 10 mg - 0.5 mg",
"amp_code": "SAM015495-00",
"strengths": [
"0.5840",
"0.5000",
"11.2500",
"10.0000",
"22.0500",
"1.2000",
"14.4000"
],
"pack_count": 1,
"substances": [
"Flupentixol Dihydrochloride",
"Flupentixol",
"Melitracen Hydrochloride",
"Melitracen",
"Lactose Monohydrate",
"Vegetable Oil, Hydrogenated",
"Betadex"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Melitracen and Psycholeptics",
"authorisation_numbers": [
"BE015495"
]
}See everything about melitracen und psycholeptika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.